Presentation is loading. Please wait.

Presentation is loading. Please wait.

Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,

Similar presentations


Presentation on theme: "Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,"— Presentation transcript:

1 Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick, Oxford University press Md. Saifuzzaman Assoc. Professor

2 Methods of parallel synthesis Houghton’s teabag procedure A manual approach to parallel synthesis More than 150 peptides at a time Polymeric support resin (100mg) – sealed in polypropylene meshed containers (3x4cm) – known as teabag Each teabag is labelled

3 Methods of parallel synthesis Houghton’s teabag procedure

4 Teabags – placed in PE bottles (reaction vessels) First a.a. added to resin ( different a.a. in different bottle) All teabags in a specific bottle – have same a.a. Teabags from every bottle – combined in 1 vessel for deprotection and washing all at a time.

5 Methods of parallel synthesis Houghton’s teabag procedure Teabags – redistributed in bottles for addition of second a.a., recombined for deprotection & washing, redistributed for addition of next a.a. and so on. Advantages – cheap, no need of expensive equipment Disadvantages – manual, so limited quantity & speed.

6 Methods of parallel synthesis automated parallel synthesis Synthesis of 6, 12, 42, 96, or 144 structures depending on instrument and size of reaction tubes Solvents, starting materials & reagents – added automatically using syringes Removal of solvent, washing & liquid-liquid separations – also automatic Reaction – can be stirred & carried out under inert atmos. Reaction – can be heated & cooled as required.

7 Methods of mixed combinatorial synthesis General principles Designed to produce a mixture of products in each vessel from wide range of starting materials & reagents Doesn’t mean that all starting materials should be put in one flask Planning has to go to design a reaction to minimize efforts & to maximize outputs

8 Methods of mixed combinatorial synthesis General principles For example, if we plan to synthesize all dipeptides of 5 different a.a., Using orthodox chemistry, we would synthesize one at a time 25 possible dipeptides, so 25 separate experiments

9 Methods of mixed combinatorial synthesis General principles Using combinatorial synthesis, same products with far less effort All 5 a.a. sperately bound to resin beads, mixed together & treated with second a.a. to produce all possible dipeptides in 5 experiments

10 Methods of mixed combinatorial synthesis General principles Mixtures – tested for activity; if positive, emphasis on identifying active dipeptides & if negative, mixtures – ignored & stored. Large numbers of mixtures –can be generated; many are inactive But they are not discarded (though no lead compound for the target but may contain lead for a different target)

11 Methods of mixed combinatorial synthesis General principles All the mixtures – stored & referred to combinatorial or compound libraries. Combinatorial library acts as a source of potential new leads.

12 Methods of mixed combinatorial synthesis General principles Thousands or millions of different structures can be produced As quantity is extremely small, huge no. of compounds – can be stored & used for further study Though exact structure is not known, a general idea of type of structure based on type of synthesis and reagents used

13 The mix and split method If huge quantities of different compounds, important to minimize the efforts involved An example illustrating the mix and split method: To make all possible tripeptides of 3 different a. a. (Gly, Val & Ala)

14 The mix and split method Stage 1: Link each amino acid to a solid support

15 The mix and split method Stage 2: Mix the beads together and separate into 3 equal portions

16 The mix and split method Stage 3: React each portion with a different a.a All 9 possible dipeptides – synthesized in 3 separate experiments Samples of each portion – retained for recursive deconvolution.

17 The mix and split method Stage 4: isolate all the beads, mix them together and split into 3 equal portions. Each portion will now have all nine possible dipeptides

18 The mix and split method Stage 5: react each portion with one of 3 a.a. All 27 possible tripeptides – synthesized in 3 experiments

19 Isolating the active component in a mixture: deconvolution Isolating & identifying the most active compound in a mixture – deconvolution 1.Micromanipulation 2.Recursive deconvolution 3.Sequential release

20 Micromanipulation Each bead contains only one structural product Individual beads – separate & product – cleaved & tested Aided by colorimetric analysis (test activity when still bound) Active beads – distinguished by colour reaction and can be picked out. Disadvantage: tedious process & problematic with large quantities of beads.

21 Recursive deconvolution Useful in cutting down amount of work involved Let us consider the libraries of tripeptides (already discussed) 3 final mixtures – suppose 1 mixture shows activity Could you synthesize all nine possible tripeptides separately? No, you have samples of the dimer mixtures produced in synthesis.

22 Recursive deconvolution Suppose third tripeptide mixture showed activity, that means the active tripeptide has Val in N-terminus Take 3 dipeptide mixtures (retained previously) & link Val to each mixture. This gives 9 tripeptides in 3 mixtures where 2 nd & 3 rd a.a. are same in each mixture.

23 Recursive deconvolution

24 Test 3 mixtures, if 1 is active we can identify 2 nd & 3 rd a.a. Suppose mixture containing Ala (2 nd ) & Val (3 rd ) is the active mixture. Finally 3 component tripeptides in the active mixture – individually synthesized & tested.

25 Sequential release Linkers – allow release of certain percentage of product from bead Process – repeated releasing product sequentially Mixture of beads – treated to release some of bound product for testing.

26 Sequential release If the mixture is active, beads – split into smaller mixture, further product – released & tested Whole process – repeat several times until active bead is identified.

27 Structure determination of active compounds Direct structure determination of components – much difficult But huge advancements in mass, NMR, Raman, infrared and ultraviolet spectrophotomentry Peptides – sequenced while attached to bead. Tagging procedure – can be used

28 Tagging Two molecules – built up on same bead One is intended structure; other is a molecular tag (peptide or oligonucleotide) as a code for each step of synthesis Bead – has multiple linker linking both target structures & molecular tags Starting material is added to 1 part & encoding a.a. or necleotide to another part.

29 Tagging After each stage, an a.a. or nucleotide is added to growing tag to indicate what reagent was used Example of multiple linker – Safety Catch Linker (SCAL) which has lys & try, both having a free amino group.

30 Tagging Target group – constructed on amino group of tryptophan moiety Tagging a.a. – built on to amino group of lysine moiety after each stage of synthesis

31 Tagging By end of the process, there is a tripeptide tag where each a.a defines the identity of variable groups R1, R2 & R3 in target structure Target group – cleaved by reducing 2 sulfoxide groups in SCAL, treat with acid Tripeptide sequence – still attached to bead, sequenced to identify structure of released compound Same strategy – with oligonucleotide as tag, Additionally oligonucleotide – amplified by replication and read by DNA sequencing

32 Tagging Drawbacks:  Time consuming  Require elaborate instrumentation  Coding structure adds extra restraints on protection & imposes limitations on reaction  For oligonucleotides, inherent instability  Possibility of unexpected reaction resulting in unwanted structure

33 Photolithography A technique that permits miniaturization and spatial resolution such that specific products are synthesized on a plate of immobilized solid support. For synthesis of peptides, solid support surface contains an a.a. protected by photolabile group, nitroveratryloxycarbonyl (NVOC)

34 Photolithography With mask part of surface – exposed to light – deprotection Plate is treated with protected a.a; coupling reaction only on deprotected region of the plate Plate – wash to remove excess a.a.

35 Photolithography The process – can be repeated on a different region using a different mask, so different peptide chains can be built on different parts of the plate Sequences can be known from record of masks used.

36 Photolithography

37 Incubation of the plate with a protein receptor – to detect active compounds that bind to receptor More convenient method – using a fluorescently tagged receptor Only regions of plate containing active compounds bind to receptor and fluoresce. Fluorescence intensity – measured using fluorescene microscopy and a measure of affinity of the compound to receptor. Also detection by radioactivity or chemiluminescence.

38 Photolithography Photodeprotection can be achieved in high resolution At 20-µm resolution, plates can be made with 250,000 compounds /cm 2.

39 Limitations of combinatorial synthesis Total natural a.a = 20 Total possible decapeptides = 10,240 billion For statistical reason, no. of beads should exceed no. of target molecules by a factor of 10 e.g., if 5 beads for each of 3.2 million components of a pentapeptide library and 1/5 is taken as sample; probability of getting all peptides is only 63%

40 Limitations of combinatorial synthesis If you use required excess of beads, beads for complete dipeptide library = 8.4 mg beads for complete tetrapeptide library = 3.4 gm (still good!!) beads for complete decapeptide library = tonnes!!!!!!!!

41 Dynamic combinatorial chemistry An exciting development in new lead discovery as an alternative to classic mix and split combinatorial synthesis In classic method, stable products are synthesized with particular route & building blocks. Then products are screened to find the most active compound. In dynamic combinatorial chemistry, synthesize all different compounds in 1 flask at same time, screen them in situ as they are being formed; thus identify the most active compound in a much shorter period of time.

42 Dynamic combinatorial chemistry Best way of screening is to have the desired target in reaction flask along with building blocks. Active compounds bind to target as soon as they are formed. Reactions should be reversible. Products are constantly being formed and then breaking back down to building blocks. Advantage is amplification. Active compounds become bound to target and removed from equilibrium mixture. Equilibrium is shifted such that more active product is formed. Thus target serves both to screen and to amplify active compounds. Necessary to freeze equilibrium reaction to identify active compounds. A further reaction can be carried out which converts all equilibrium products into stable products that cannot revert back to starting materials

43 Dynamic combinatorial chemistry Limitations:  Condition such that target does not react with any building block or unstable under reaction conditions  Target is normally in aqueous environment, so reactions have to be in aqueous solution.  Reactions should undergo fast equilibrium rates to allow amplification  Avoid using some building blocks which are more reactive than others, as this would bias the equilibrium and confuse the identification.

44 Planning & designing a combinatorial synthesis ‘Spider like’ scaffolds’ To find a new lead compound, we need a large no. of diverse structures. Best to synthesize ‘spider-like’ molecules consisting of a central body (centroid/scaffold) & various arms (substituents)

45 Planning & designing a combinatorial synthesis ‘Spider like’ scaffolds’ Arms contain different functional groups to probe a binding site Chance of success is greater if arms are spreaded around scaffold Allows more theoretical explanation of 3D space or conformational space around the molecule

46 Planning & designing a combinatorial chemistry ‘Spider like’ scaffolds’ Plan in advance such that synthesized molecules contain different functional groups on arms & different distances from scaffold In general, this approach increases the chances of finding a lead compound that interacts with a target binding site.

47 Planning & designing a combinatorial chemistry Designing ‘drug-like’ molecules Compounds with good binding interactions do not necessarily make good medicines. Pharmacokinetic issues also to be taken into account. Certain restrictions to type of molecules in order to increase chance of getting orally active lead compounds

48 Planning & designing a combinatorial chemistry Designing ‘drug-like’ molecules Chances of oral activity is increased if structure obeys Lipinski’s rule of five:  M.W < 500  Log P < +5  H-bond donating groups ≤ 5  H-bond accepting groups ≤ 10

49 Planning & designing a combinatorial chemistry Designing ‘drug-like’ molecules Groups should be avoided:  Esters (liable to easy metabolism)  Alkylating groups (toxic)  Aromatic amino groups (toxic)

50 Planning & designing a combinatorial chemistry Scaffolds Synthesized by synthetic route used for combinatorial synthesis Synthesis determines no. & variety of substituents Ideal scaffold is small & allows a wide variety of substituents

51 Planning & designing a combinatorial chemistry Scaffolds Its substituents are dispersed widely around its structure (spider-like), not restricted to part of structure (tadpole-like) Synthesis allows substituents to be varied independently of each other.

52 Planning & designing a combinatorial chemistry Scaffolds Can be flexible (peptide backbone) or rigid (a cyclic system) May contain groups useful for binding interactions Some scaffolds are common called ‘privileged scaffolds’. e.g., benzodiazepine, hydantoin, tetrahydroisoquinoline, benzenesulfonamide, etc.

53 Planning & designing a combinatorial chemistry Substituent variation Choice of substituents depends on availability and diversity required Consider followings: Structure, size, shape, lipophilicity, dipole moment, electrostatic charge and functional groups present.

54 Planning & designing a combinatorial chemistry Designing compound libraries for lead optimization To optimize a lead, consider following factors for planning of variations: biological & physical properties of compound binding interactions, and potential problems of particular substituent

55 Planning & designing a combinatorial chemistry Computer-designed libraries Computer software programs to design more focused combinatorial compound libraries. Descriptors: log P, molecular weight, no. of H-bond donors, no. of H-bond acceptors, no. of rotatable bonds, aromatic density, degree of branching in structure, and presence or absence of specific functional groups.

56 Testing for activity High-throughput screening (HTS) A process of biological testing of a large quantity of structures quickly and automatically HTS was developed before combinatorial chemistry and acted as driving force for synthesizing huge quantity of structures to meet rapid & efficient biological testing process (HTS)

57 Testing for activity High-throughput screening (HTS) Compounds tested on 96 well plate, capacity of each well being 100 μl Currently same size plate of 1536 wells containing 1-10 μl Fluorescence, chemiluminescence developed for simultaneous identification of active wells.

58 Testing for activity High-throughput screening (HTS) Next major advancement is microfluidics that involves manipulation of tiny volumes of liquids in confined space. Microfluidic circuits to control fluid electronically, separation using capillary electrophoresis New machines for both ultra-small-scale synthesis & miniaturized analysis 10x10 cm silicon wafer for 10 5 synthesis/bioassay on nl scale.

59 Testing for activity Screening ‘on bead’ vs ‘off bead’ Structures can be tested when still attached to solid phase It involves interactions with targets tagged to enzyme, fluorescent probe, radionuclide or chromophore. Rapid & 10 8 beads can be screened Active beads picked out by micromanipulation & structure of active compound determined.

60 Testing for activity Screening ‘on bead’ vs ‘off bead’ False negative may be obtained if solid phase sterically interferes assay In such case, better to release drug from solid phase and test to avoid false (-)ve However, some compounds are insoluble in test assay and give false (-)ve result in solution but (+)ve result when attached to bead.


Download ppt "Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,"

Similar presentations


Ads by Google